Over the last 10 years racial and ethnic minorities are significantly underrepresented in rheumatoid arthritis clinical trials with no hope for improvement in the future. How applicable are these results when they do not reflect the population? #ACR19 abstract# 1160 https://t.co/WNSGfyCSKu